Vitamin C in Post-cardiac Arrest

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 270 participants.

Also called NCT03509662

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 270 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03509662
Other papers using this trial's data
  • Early high-dose vitamin C for out-of-hospital cardiac arrest: the VITaCCA randomized clinical trial Intensive care medicine, 2026-07 DOI, PubMed 42301311, PMC13342416 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03509662. Randomized; quadruple masking; primary purpose treatment. Start 2019-10-07 (actual); primary completion 2024-02-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Vitamin C in Post-cardiac Arrest
Acronym
VITaCCA
Intervention (Drug)
Vitamin C
Intervention (Drug)
Thiamine
Intervention (Drug)
Placebos
Lead sponsor
Amsterdam UMC, location VUmc (class: other)
Collaborator
Gelderse Vallei Hospital (class: other)
Collaborator
Sint Franciscus Gasthuis (class: other)
Collaborator
Tergooiziekenhuizen (class: not stated)
Collaborator
Amphia Hospital (class: other)
Collaborator
Erasmus Medical Center (class: other)
Collaborator
Noordwest Ziekenhuisgroep (class: other)
Collaborator
Maasstad Hospital (class: other)
Collaborator
OLVG (class: research network)

Record details

Record id
cardio:ct-nct03509662
Content hash
0b25d9868d597e12292380d17fa9154ac7336aa3a841061f04f71cfd97883021